Trademarkia Logo

Canada

C$
Trademark Search in Canada
EBESANAR

View On IC.GC.CA

EBESANAR
APPROVED

on 16 May 2025

Last Applicant/ Owned by

RHEACELL GmbH & Co. KG

Im Neuenheimerfeld 51769120 Heidelberg

DE

Serial Number

2245803 filed on 7th Dec 2022

Correspondent Address

ERIN MCEWEN

NELLIGAN O'BRIEN PAYNE LLP 50 O'Connor StreetSuite 300Ottawa,

ONTARIO

CA

K1P6L2

EBESANAR

Trademark usage description

stem cells for scientific use; stem cells for research use; cell growth media for growing cells for scientific use; stem cells others than for medical Read More

Classification Information

Class [001]
Stem cells for scientific use; stem cells for research use; cell growth media for growing cells for scientific use; stem cells others than for medical or veterinary purposes, namely stem cells for aesthetic purposes excluding all medical or veterinary purposes;

Classification kind code

11

Class [005]
Drugs for medical purposes, namely, pharmaceutical preparations for treating skin diseases and skin disorders; pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for treating skin diseases and skin disorders; diagnostic agents, namely diagnostic radiopharmaceutical agent for use in PET imaging; pharmaceutical preparations, namely, pharmaceutical preparations for treating skin diseases and skin disorders; preparations for medical purposes, namely, pharmaceutical preparations for treating skin diseases and skin disorders; preparations for biomedical purposes, namely, pharmaceutical preparations for treating skin diseases and skin disorders; pharmaceutical cell preparations for treating skin diseases and skin disorders; substances for medical use, namely, pharmaceutical preparations for treating skin diseases and skin disorders; substances for biomedical purposes, namely, pharmaceutical preparations for treating skin diseases and skin disorders; live implants for pharmaceutical purposes, namely implants comprising living tissue for pharmaceutical purposes; biochemical and chemical products for medical use, namely, pharmaceutical preparations for treating skin diseases and skin disorders; biochemical and chemical products for pharmaceutical purposes, namely, pharmaceutical preparations for treating skin diseases and skin disorders; biochemical and chemical diagnostic preparations for medical purposes; proteins for medical purposes, namely, protein arrays for medical diagnosis purposes; biological preparations for medical and veterinary purposes, namely, pharmaceutical preparations for treating skin diseases and skin disorders; pharmaceutical and veterinary preparations for external and systemic use, namely, pharmaceutical preparations for treating skin wounds; biological, pharmaceutical and veterinary preparations for skin care for medical purposes, namely, pharmaceutical preparations for treating skin diseases and skin disorders; medical dressings; preparations for wound treating and healing, namely, pharmaceutical preparations for treating skin wounds; stem cells for medical purposes; stem cells for veterinary purposes; somatic stem cell therapeutics, namely, somatic stem cells for medical or veterinary use; fibroblasts for medical purposes; fibroblasts for surgical beauty purposes; pharmaceutical implants, namely implantable pharmaceutical preparations for treating cancer; surgical implants derived from stem cells; surgical implants derived from fibroblasts; cells for medical use in the nature of biological tissue for implantation; growth media for culturing cells for medical purposes; pharmaceutical preparations for tissue regeneration; living tissue, namely vascular grafts; biotechnologically engineered tissue products, namely, cells for medical use;

Classification kind code

11

Class [042]
Pharmaceutical drug development; scientific and technological services, namely, scientific research in the field of genetics; research and development services in the fields of cell diagnostics, cell therapy; industrial analysis and research services, namely analysis of industrial fluids and medical research, chemical analysis; scientific research for medical purposes in the field of stem cell therapies; stem cell research; scientific and medical research and development in the field of stem cells; scientific research, testing and analysis services of the services of others to determine conformity with certification standards and in the field of regenerative medicine and tissue engineering; medical research; biomedical research; research and development in the field of biotechnology; research and development in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; industrial process research, namely, research and development of new products; research and development services for the pharmaceutical industry; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information about medical and scientific research for pharmaceutical products;

Classification kind code

11

Class [044]
Medical services relating to the removal, treatment, processing and storage of human cells and tissue, stem cells and bone marrow, medical services in the field of regenerative medicine; medical diagnostic services [carrying out tests and analyses]; medical assistance; health clinic services; hospital services; plastic and cosmetic surgery; medical therapies, namely, providing laser therapy for treating medical conditions; medical services in the field of regenerative medicine; medical services relating to the cultivation and procurement of stem cells; medical services in connection with the cultivation and procurement of stem cells.

Classification kind code

11

Mark Details

Serial Number

2245803

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 5th Dec 2024		Agent Changed
Submitted for opposition 22
on 14th Jun 2024		Search Recorded
Submitted for opposition 20
on 14th Jun 2024		Examiner's First Report
Submitted for opposition 223
on 14th Jun 2024		Total Provisional Refusal
Submitted for opposition 256
on 16th Jan 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 16th Mar 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 15th Mar 2023		Created
Submitted for opposition 31
on 15th Mar 2023		Formalized
Submitted for opposition 30
on 7th Dec 2022		Filed
Submitted for opposition 228
on 7th Dec 2022		International Registration